Lupus patients in England in remission after pioneering NHS trial of GM therapy

AI Summary

Five lupus patients in England have gone into remission following a pioneering NHS trial using genetically modified T-cell therapy. This breakthrough treatment involves engineering patients' own immune cells to target and destroy the disease, offering hope for curing chronic autoimmune conditions.

Doctors say therapy that genetically modifies person’s T-cells could offer cure for chronic autoimmune disease Five lupus patients in England are in remission after being treated with a revolutionary therapy that genetically modifies their own cells, in a medical breakthrough that could offer people a cure, doctors have said. CAR (chimeric antigen receptor) T-cell therapy involves removing a type of white blood cell also called T lymphocytes, which are crucial for hunting out infected or damaged cells, and engineering them to spot and destroy disease. The T-cells are then fed back into the patient via an infusion to reset their immune system. Continue reading...